Insights

David Rubin, MD, chief of gastroenterology, hepatology, and nutrition at the University of Chicago, reviews his presentation from the Advances in Inflammatory Bowel Diseases regional meeting on the newly-approved, first-in-class S1P receptor...

Dr Cohen recaps his presentation from the Advances in Inflammatory Bowel Disease regional meeting held on August 7 on the use of anti-integrins and anti-tumor necrosis factor therapies for treating Crohn disease and ulcerative colitis.

Miguel Regueiro, MD, the chair for Advances in Inflammatory Bowel Diseases 2021 regional events, previews the topics and activities for the AIBD regional meeting on August 7.

In this podcast, Dr Barnes, from the University of North Carolina at Chapel Hill, discusses his recent research into the prevalence of pouchitis among patients who have undergone ileal pouch-anal anastamosis surgery.

In this episode of IBD Drive Time, hosts Raymond Cross, MD, and Millie Long, MD, interview David Rubin, MD, chief of gastroenterology, hepatology, and nutrition at the University of Chicago, on using newly-approved ozanimod in treating...

In this podcast, Erica Brenner, MD, and Manasi Agrawal, MD, discuss some highlights and important takeaways from their study, COVID‑19 Outcomes Among Racial and Ethnic Minority Individuals with Inflammatory Bowel Disease in the United States.

In this video, Dr Regueiro, chair for Digestive Disease and Surgery Institute at Cleveland Clinic in Cleveland and Inflammatory Bowel Disease Section Editor for Gastroenterology Learning Network, discusses managing the patient hospitalized...

Dr Barnes discusses the factors to consider when determining when and how to position therapeutic options, including surgery, for patients with ulcerative colitis.

Dr Dubinsky, codirector of the Susan and Leonard B Feinstein IBD Center at the Icahn School of Medicine in New York, discusses the importance of addressing bowel urgency with patients who have ulcerative colitis.

In this podcast, Dr Marc Rhoads discusses highlights from his recent presentation at the Advances in Inflammatory Bowel Disease 2021 Regional conference.